NCT00780832View on ClinicalTrials.gov

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

NATerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
Overactive Bladder
Interventions
BEHAVIORAL

Dietary Caffeine reduction

Participants are counseled about reduction of dietary caffeine, given written information and a bladder control log.

DRUG

Anticholinergic medication

Detrol LA 4mg. orally, once daily for 30 days

Trial Locations (1)

B3K 6R8

IWK Health Centre, Halifax

Sponsors

Lead Sponsor

IWK Health Centre
All Listed Sponsors
lead

IWK Health Centre

OTHER

NCT00780832 - Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder | Biotech Hunter | Biotech Hunter